BrightSpring Health Services (BTSG) Stock Price, News & Analysis

Company Overview

BrightSpring Health Services, Inc. is a provider of home- and community-based health services and pharmacy services in the United States. The company supports individuals who require assistance with daily living, clinical care, rehabilitation, behavioral health services, or other long-term and post-acute care.

Its businesses include home health, hospice, personal care, residential and community living services, behavioral health programs, primary care, and rehabilitation. Through its PharMerica pharmacy business, BrightSpring provides institutional and specialty pharmacy services, including medication dispensing and related clinical support for long-term care facilities and other healthcare settings.

BrightSpring serves patients and clients across the United States through a network of local operations and care professionals. The company is headquartered in Louisville, Kentucky. Jon B. Rousseau serves as its president and chief executive officer. BrightSpring became a publicly traded company on the Nasdaq under the symbol BTSG in 2024.

Key Stats

• Today's Range: $55.52 to $56.79
• 50-Day Range: $55.86 to $72.91
• 52-Week Range: $26.28 to $73.75
• Volume: 1.73 million shs
• Average Volume: 2.94 million shs
• Market Capitalization: $11.04 billion
• P/E Ratio: 33.60
• Dividend Yield: N/A
• Price Target: $70.71
• Consensus Rating: Buy

BrightSpring Health Services Stock Analysis - MarketRank™

BrightSpring Health Services scored higher than 94% of companies evaluated by MarketBeat, and ranked 22nd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.6 / 5
• Analyst Rating: Buy

Consensus Rating

BrightSpring Health Services has received a consensus rating of Buy. The company's average rating score is 3.10, and is based on 2 strong buy ratings, 18 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

BrightSpring Health Services has a consensus price target of $70.71, representing about 26.5% upside from its current price of $55.87.

Amount of Analyst Coverage

BrightSpring Health Services has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 24.18%

Earnings Growth

Earnings for BrightSpring Health Services are expected to grow by 24.18% in the coming year, from $1.82 to $2.26 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of BrightSpring Health Services is 33.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.04.

Price to Earnings Ratio vs. Sector

The P/E ratio of BrightSpring Health Services is 33.65, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.96.

Price to Earnings Growth Ratio

BrightSpring Health Services has a PEG Ratio of 0.65. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

BrightSpring Health Services has a P/B Ratio of 5.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.28% of the float of BrightSpring Health Services has been sold short.

Short Interest Ratio / Days to Cover

BrightSpring Health Services has a short interest ratio ("days to cover") of 4.8.

Change versus previous month

Short interest in BrightSpring Health Services has recently increased by 14.89%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

BrightSpring Health Services does not currently pay a dividend.

Dividend Growth

BrightSpring Health Services does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 1.10

News Sentiment

BrightSpring Health Services has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for BrightSpring Health Services this week, compared to 4 articles on an average week.

Search Interest

Only 11 people have searched for BTSG on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.

MarketBeat Follows

16 people have added BrightSpring Health Services to their MarketBeat watchlist in the last 30 days. This is an increase of 45% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, BrightSpring Health Services insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.80% of the stock of BrightSpring Health Services is held by insiders.

Percentage Held by Institutions

BrightSpring Health Services has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/31/2026
• Today: 9/23/2026
• Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum: 9/24/2026
• Next Earnings (Estimated): 10/19/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:BTSG
• Previous Symbol: NASDAQ:BTSG
• CIK: 1865782
• Web: www.brightspringhealth.com
• Phone: 502-394-2100
• Fax: N/A
• Employees: 23,500
• Year Founded: 1974

Price Target and Rating

• Average Price Target for BrightSpring Health Services: $70.71
• High Price Target: $90.00
• Low Price Target: $36.00
• Potential Upside/Downside: +26.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.10
• Research Coverage: 20 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.66
• Trailing P/E Ratio: 33.60
• Forward P/E Ratio: 30.65
• P/E Growth: 0.65
• Net Income: $190.67 million
• Net Margins: 2.55%
• Pretax Margin: 2.06%
• Return on Equity: 16.73%
• Return on Assets: 5.24%

Debt

• Debt-to-Equity Ratio: 1.06
• Current Ratio: 1.59
• Quick Ratio: 1.22

Sales & Book Value

• Annual Sales: $12.91 billion
• Price / Sales: 0.85
• Cash Flow: $2.19 per share
• Price / Cash Flow: 25.42
• Book Value: $10.40 per share
• Price / Book: 5.36

Miscellaneous

• Outstanding Shares: 197,860,000
• Free Float: 192,324,000
• Market Cap: $11.04 billion
• Optionable: Optionable
• Beta: 1.84